Rhythm Biosciences Limited (ASX:RHY)

Rhythm Biosciences Limited (ASX:BGT)

Rhythm Biosciences (ASX:RHY) is an Australian biotech company working on a simple, affordable and effective blood test, ColoSTAT™, for the early detection of colorectal cancer.

 

Alphastation was engaged in Q2 2017 in preparation for its listing on the ASX in December 2017.  Alphastation assisted Rhythm Biosciences including:

  • Completion of the raw IPO prospectus for the company’s $9 million capital raising on the ASX including content drafting and refinement
  • Defined communication strategy and positioning aligned to the Rhythm Biosciences corporate strategy
  • Liaison with company management, Board of Directors, legal advisor to the offers and broker to ensure project was delivered before deadline
  • Conceived diagrams and flowcharts to convey the technology, product and market story that went to external design team
  • Completion of business plan to underpin the company growth plan
Client since

2017

Category
IPO Prospectus